Interestingly, these gene correction levels were similar to those achieved in parallel transduction experiments in which isogenic AdV.Cas9EX51 particles were used instead for targeted DMD repair in DMD.Δ48-50 myoblasts (Supplementary Fig. S3). This evidence concerns the gene DMD and Duchenne muscular dystrophy.